Navigation Links
Yet Another Treatment Option For Cancer

Researchers now say they’ve found one drug that may successfully treat everything from breast to prostate cancer.//
In a study of 22 patients with breast, prostate, lung, ovarian, colon and pancreatic cancer, 42 percent had their tumors either stabilize or shrink by more than 50 percent. Specialists say , it turns off one of the switches within the cancer cell to stop it from growing, and so there’s much less side effects because it targets the cancer, rather than targeting the whole body. According to researchers it is effective in treating Lung cancer, ovarian cancer, breast cancer, prostate cancer and several others.

Not only did early trials show it might help different types of cancer but it was also found to be effective against the toughest to treat cancers . Thus specialists say that the new findings have given them some hope as they can now take patients with advanced cancer and give them a therapy with very few side effects that stops the growth of the disease.

Since 2C4targets the pathway, rather than the tumor, it has little toxicity. However researchers say the drug is being tested in hundreds of patients worldwide and researchers are currently recruiting patients with lung or prostate cancer.


'"/>




Page: 1

Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Another injectable contraceptive Pill approved by FDA
3. The Possibility Of Fighting HIV with Another Virus Questioned
4. New Research Has Found Another Use For Botox
5. Yet Another Harmful Consequence Of Smoking
6. Another Treatment Option for Benign Tumors
7. Another Alternative For Diabetics On Insulin
8. Another Use For Epilepsy Drugs
9. Another Cause of Thyroid Cancer Discovered
10. Yet Another Use For Cell Phone Cameras
11. Yet Another Use For Cocoa Flavonols
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Yet Another Treatment Option For Cancer

(Date:7/20/2008)... New specialization from online universit...ies; helps address nationwide shortage of nursing ... (PRWEB) July 20, 2008 -- Capella University ( www...based in Minneapolis, has announced a new PhD in E...aligns with National League of Nursing (NLN) compe...
(Date:7/19/2008)...of non-Hodgkin disease puts older men chiefly at r...ealthDay News) -- The prevalence of mantle cell ly..., is increasing, and most patients are diagnosed w...by researchers at the University of Texas M.D. And... a fast-growing, incurable cancer of the immune sy...
(Date:7/19/2008)... likely to be iron-deficient, study finds , ...who are predominantly breast-fed for the first six...stinal problems. But, they,re more likely to be de...according to a study that looked at 154 mothers an...e verifying previous findings that in low-income c...
(Date:7/18/2008)...on the wagon an antidepressant restored brain,s ab... 18 (HealthDay News) -- Giving up your few drinks ...ion, a new study says. , "Our research in an an...nence from alcohol drinking and depression," study...hiatry and pharmacology in the University of North...
Breaking Medicine News(10 mins):Health News:Capella University Launches Online PhD Specialization in Nursing Education 2Health News:Capella University Launches Online PhD Specialization in Nursing Education 3Health News:Incidence of Mantle Cell Lymphoma on Rise 2Health News:Breast-Fed Babies Have Fewer GI Infections 2Health News:Research Finds Causal Link Between Ending Drinking, Depression 2
...n's Hospital in San Francisco have launched a grou...ure// using magnets can correct sunken chest, the ...e way that orthodontic braces gradually realign te...ically as pectus excavatum, is a deformity of the ...
...e infected with bird flu have been under the age o.../ to the latest analysis from the World Health Org... analysis did not suggest why this might be and no...ies on why the H5N1 virus seems to attack younger ...
...ompany Medivir announced yesterday that it has lic...anscriptase inhibitor (NNRTI), code-named MIV-160,...Pharmaceutical for the China region. Medivir will ...duct. Guangdong Lantai Viewland Pharmaceutical w...
...roportions will soon be established as part of U.S... Kaiser// Permanente Research Program on Genes, En...nlist around half a million volunteers from its ad... its research. Kaiser Permanente is planning to c...
Other Medicine News:Health News:Study to Explore Using Magnets to Correct 'sunken Chest' 2Health News:Study to Explore Using Magnets to Correct 'sunken Chest' 3Health News:Giant Healthcare Provider to Set Up Massive Gene Bank 2
(Date:7/18/2008)...ewswire/ -- Velcura Therapeutics, Inc.,CEO Michael...f has joined,the Board of Directors of the biotech...nical trial for VEL-0230, a powerful anti-inflamma...ng bone loss. Velcura is,investigating its lead co...,other bone diseases., Bill Brinkerhoff is the ch...
(Date:7/17/2008)...ewswire/ -- The research team at the,Nemours Cente...stablished,division of Nemours Biomedical Research... discovered that the biomarker called prostate spe...in cancer cells of patients,with advanced prostate...n,of cancer to an aggressive disease. A biomarker ...
(Date:7/17/2008)...wswire/ -- Impliant, Inc., a developer of,novel sp...oday announced,that it conducted the first surgery...n of its TOPS(TM) System, a Total Posterior,Arthro...th or without facet,arthrosis and spondylolisthesi... Neurosurgeon at the Charlotte Neurosurgery and Sp...
(Date:7/17/2008)...wswire-USNewswire/ -- Strong National,Museum of Pl...f the,American Journal of Play, the first interdis... study of play., The inaugural issue enters the s...content from some of the most prominent national,r...cientist,s assertion,that the rising tide of ADHD ...
Breaking Medicine Technology:Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors 2Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer 2Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer 3Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System 2Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008 2Spherix Shareholders Support Companys Focus on Naturlose Biotechnology 23 1Spherix Shareholders Support Companys Focus on Naturlose Biotechnology 23 2Spherix Shareholders Support Companys Focus on Naturlose Biotechnology 23 3Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo 28TM 29 Program 19 1Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo 28TM 29 Program 19 2Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community 15 1Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community 15 2Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community 15 3Johns Hopkins to add Elekta Synergy S 28R 29 to Cancer Treatment Lineup 11 1Johns Hopkins to add Elekta Synergy S 28R 29 to Cancer Treatment Lineup 11 2Johns Hopkins to add Elekta Synergy S 28R 29 to Cancer Treatment Lineup 11 3
Each handle is designed to fit a specific trephine size.
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers.
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers.
Each handle is designed to fit a specific trephine size.
Medicine Products: